Merck and Isomorphic Labs said they are entering into a research collaboration to discover small molecule candidates in oncology.
The partnership pairs Merck's drug development work with Isomorphic Labs' artificial intelligence approach to drug discovery, with the goal of identifying new cancer treatment candidates.S1S2